Table 4.
Comparing Events Based on Organisms for CLABSI and CAUTI Pre–COVID-19 to Pandemic Periods
| Variable | Before COVID-19 (March 2019–February 2020) | During the COVID-19 Pandemic (March-August 2020) | Before COVID-19 vs During COVID-19 | |||||
|---|---|---|---|---|---|---|---|---|
| No. of Events (Organismsa) | Device Days | Rate (Events per 1,000 Device Days) | No. of Events (Organismsa) | Device Days | Rate (Events per 1,000 Device Days) | P Value | Relative Change, % | |
| CLABSI | 302 (344) | 537,124 | 0.56 | 219 (236) | 257,898 | 0.85 | <.001 | 51.0 |
| Gram-positive organisms | 143 (155) | 537,124 | 0.27 | 124 (129) | 257,898 | 0.48 | <.001 | 80.6 |
| Staphylococcus aureus | 53 (53) | 537,124 | 0.10 | 33 (33) | 257,898 | 0.13 | .24 | 29.7 |
| Methicillin resistant Staphylococcus aureus |
21 (21) | 537,124 | 0.04 | 16 (16) | 257,898 | 0.06 | .16 | 58.7 |
| Coagulase-negative Staphylococcus | 39 (42) | 537,124 | 0.07 | 43 (44) | 257,898 | 0.17 | <.001 | 129.6 |
| Gram-negative organisms | 103 (112) | 537,124 | 0.19 | 48 (50) | 257,898 | 0.19 | .86 | −2.9 |
| Candida spp | 73 (76) | 537,124 | 0.14 | 55 (55) | 257,898 | 0.21 | .01 | 56.9 |
| CAUTI | 471 (535) | 546,952 | 0.86 | 209 (237) | 270,315 | 0.77 | .19 | −10.2 |
| Gram-positive organisms | 100 (106) | 546,952 | 0.18 | 52 (52) | 270,315 | 0.19 | .77 | 5.2 |
| Gram-negative organisms | 392 (429) | 546,952 | 0.72 | 168 (185) | 270,315 | 0.62 | .12 | −13.3 |
Note. CLABSI, central-line–associated bloodstream infection; CAUTI, catheter-associated urinary tract infection.
a
Rates are based on events; >1 organism may be associated with an event.